Chemotherapy

Revumenib proved safe and effective among pediatric and adult patients with relapsed or refractory KMT2Ar acute myeloid leukemia and acute lymphoid leukemia, according to study results presented at ASH Annual Meeting and Exhibition.

SAN DIEGO — Oral arsenic trioxide proved safe and effective when used as part of a regimen for treatment of acute promyelocytic leukemia, study results presented at ASH Annual Meeting and Exhibition showed.

Treatment with selpercatinib for advanced RET fusion-positive non-small cell lung cancer resulted in significantly longer PFS compared with platinum-based chemotherapy with or without pembrolizumab, study results showed.

MADRID — This year’s ESMO Congress included research updates that provide valuable data on chemotherapy-free treatment options being explored in recurrent ovarian cancer.

The combination of a sensitizing drug and stereotactic body radiation therapy improved treatment outcomes among patients with locally advanced pancreatic cancer, according to study results published in The Lancet Oncology.

To address ongoing chemotherapy drug shortages, ASCO convened a multidisciplinary panel of oncologists, ethicists and patient advocates to expedite clinical guidance for navigating care where rationing or alternative therapies are needed.

Persistent chemotherapy-related amenorrhea was common and associated with worse long-term quality of life for premenopausal women with breast cancer, according to findings published in JAMA Network Open.

Substantial progress has been made in decreasing cancer care disparities among sexual and gender minorities since ASCO’s 2017 position statement on the subject, according to a report published in JCO Oncology Practice.

Compared with white women, Black women with a low-risk form of endometrial cancer less frequently received a hysterectomy and had lower survival rates, according to research conducted at Cedars-Sinai Cancer Center.

The number of cancer surgeries, chemotherapy treatments and radiation treatments declined dramatically during the first months of the COVID-19 pandemic, study findings published in JAMA Oncology showed.